Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2-Reference-Cited by-同舟云学术

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2

Published:2015-01 Issue:1 Volume:51 Page:45-54
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Oudard Stéphane,Culine Stéphane,Vano Yann,Goldwasser François,Théodore Christine,Nguyen Thierry,Voog Eric^ORCID,Banu Eugeniu,Vieillefond Annick,Priou Franck,Deplanque Gaël,Gravis Gwenaëlle,Ravaud Alain,Vannetzel Jean Michel,Machiels Jean-Pascal,Muracciole Xavier,Pichon Marie-France,Bay Jacques-Olivier,Elaidi Reza,Teghom Corine,Radvanyi François,Beuzeboc Philippe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005

3. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder;Dash;Cancer,2006

4. Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group;Linardou;Urology,2004

5. New developments in urothelial cancer;Galsky;Am Soc Clin Oncol Educ Book,2012

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas;Cancers;2024-09-13

2. Contemporary Molecular Markers for Predicting Systemic Treatment Response in Urothelial Bladder Cancer: A Narrative Review;Cancers;2024-09-01

3. Landscape of targeted therapies for advanced urothelial carcinoma;Exploration of Targeted Anti-tumor Therapy;2024-06-21

4. Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma;Molecules;2024-04-22

5. Antibody–Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data;Current Oncology;2024-04-19